APA (7th ed.) Citation

S, M. B., DJ, C., SM, D., NW, K., BGC, L., X, W., . . . D, K. (2025). A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID. Nature communications, 16(1), 2900. https://doi.org/10.1038/s41467-025-57905-4

Chicago Style (17th ed.) Citation

S, M Bader, et al. "A Novel PLpro Inhibitor Improves Outcomes in a Pre-clinical Model of Long COVID." Nature Communications 16, no. 1 (2025): 2900. https://doi.org/10.1038/s41467-025-57905-4.

MLA (9th ed.) Citation

S, M Bader, et al. "A Novel PLpro Inhibitor Improves Outcomes in a Pre-clinical Model of Long COVID." Nature Communications, vol. 16, no. 1, 2025, p. 2900, https://doi.org/10.1038/s41467-025-57905-4.